Amrutanjan Healt Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'16
Mar'15
Mar'14
Mar'13
Mar'12
Mar'11
No of Months
12
12
12
12
12
12
Profit Before Tax
32.68
24.15
19.38
15.47
16.12
15.60
Adjustment
-1.31
0.33
3.51
3.05
2.73
-1.36
Changes In working Capital
0.81
3.22
1.91
-4.38
-10.13
-4.06
Cash Flow after changes in Working Capital
32.19
27.69
24.80
14.15
8.72
10.18
Cash Flow from Operating Activities
20.70
18.32
17.45
8.62
3.62
5.70
Cash Flow from Investing Activities
4.16
-4.89
16.49
7.73
14.50
-29.43
Cash Flow from Financing Activities
-13.10
-11.93
-13.92
-14.26
-27.31
19.78
Net Cash Inflow / Outflow
11.76
1.49
20.02
2.09
-9.19
-3.95
Opening Cash & Cash Equivalents
30.67
29.17
9.15
7.06
24.43
28.38
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
42.42
30.67
29.17
9.15
15.24
24.43
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Amrutanjan Healt
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
326833398
-7.95
32,68,33,405.00
4111112024.53%
Adjustment
-13061185
-9.87
-1,30,61,176.00
-132332068.19%
Changes In working Capital
8114501
-8.58
81,14,509.00
94574703.73%
Cash Flow after changes in Working Capital
321886714
-26.4
32,18,86,740.00
1219267956.06%
Cash Flow from Operating Activities
206988327
-27.37
20,69,88,354.00
756259972.12%
Cash Flow from Investing Activities
41613603
64.98
4,16,13,539.00
64040532.50%
Cash Flow from Financing Activities
-131041992
-2.66
-13,10,41,990.00
-4926390576.69%
Net Cash Inflow / Outflow
117559938
34.95
11,75,59,904.00
336365960.09%
Opening Cash & Cash Equivalents
306665123
47.17
30,66,65,076.00
650127360.25%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
424225061
82.13
42,42,24,979.00
516528648.33%
Cash Flow - Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 82.37% vs 38.31% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
50.90
27.91
82.37%






